Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Am J Kidney Dis. 2019 Oct 10;74(6):811–821. doi: 10.1053/j.ajkd.2019.06.006

Table 2:

Approximate Population-Attributable Risk Estimates for Genetic Disorders and Incidence in African Americans

Genetic Variant Population Prevalence ESKD Population Attributable Risk %
APOL1 High Risk ESKD in general population26 13% 19%
Diabetic Kidney Disease27 15% 13%
High Risk APOL1 and Biopsy-proven FSGS-ESKD18 13% 67%
High Risk APOL1 and Biopsy-proven Hypertensive ESKD9 13% 45%
High Risk APOL1 and HIVAN-ESKD 13% 78.4%
Sickle Cell Trait12 8% 9.9%
NPHS1 T233A58 - 1.1%
NPHS1 Y1174H (protection)58 - 2.43%
NPHS1 H800R (protection)58 - 4.56%
*

Population Attributable Risk (PAR) percent calculated: PAR= Pe (RRe −1)/1+ Pe (RRe −1) ×100,97,98 where Pe is the prevalence of the exposure and RRe is the relative risk of disease due to that exposure.